(Q48869486)

16 February 2018

title

Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats. (English)

1 reference

16 February 2018

author name string

F Jenck

series ordinal

1

1 reference

16 February 2018

J R Martin

series ordinal

2

1 reference

16 February 2018

J L Moreau

series ordinal

3

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 November 1996

1 reference

16 February 2018

European Neuropsychopharmacology

published in

1 reference

16 February 2018

volume

6

1 reference

16 February 2018

page(s)

291-298

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Learning motivated by electrical stimulation of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

The effect of antidepressants on aversive periaqueductal gray stimulation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Panic disorder. Pathophysiology and drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Sensations Evoked by Stimulation in the Midbrain of Man

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Cholecystokinin and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

Escape and approach induced by brain stimulation:A parametric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

New findings in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

CCK antagonists: pharmacology and therapeutic interest.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900033-8

7 January 2021

10.1016/S0924-977X(96)00033-8

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

8985712

1 reference

16 February 2018